DD116239A5 - - Google Patents

Info

Publication number
DD116239A5
DD116239A5 DD183614A DD18361475A DD116239A5 DD 116239 A5 DD116239 A5 DD 116239A5 DD 183614 A DD183614 A DD 183614A DD 18361475 A DD18361475 A DD 18361475A DD 116239 A5 DD116239 A5 DD 116239A5
Authority
DD
German Democratic Republic
Application number
DD183614A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD116239A5 publication Critical patent/DD116239A5/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
DD183614A 1974-01-14 1975-01-13 DD116239A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (en) 1974-01-14 1974-01-14

Publications (1)

Publication Number Publication Date
DD116239A5 true DD116239A5 (en) 1975-11-12

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
DD183614A DD116239A5 (en) 1974-01-14 1975-01-13

Country Status (27)

Country Link
JP (2) JPS58407B2 (en)
AT (1) AT345449B (en)
AU (1) AU500250B2 (en)
BE (1) BE824372A (en)
CA (1) CA1049406A (en)
CH (1) CH589453A5 (en)
CS (1) CS191254B2 (en)
DD (1) DD116239A5 (en)
DE (1) DE2500785B2 (en)
DK (1) DK140003B (en)
ES (1) ES433759A1 (en)
FI (1) FI54053C (en)
FR (1) FR2257305B1 (en)
GB (1) GB1498261A (en)
HK (1) HK56380A (en)
HU (1) HU173920B (en)
IE (1) IE40794B1 (en)
IL (1) IL46426A (en)
MY (1) MY8100204A (en)
NL (1) NL166622C (en)
NO (1) NO143128C (en)
PH (1) PH14458A (en)
PL (1) PL93689B1 (en)
SE (1) SE427238B (en)
SU (1) SU616997A3 (en)
YU (1) YU41289B (en)
ZA (1) ZA75259B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (en) * 1977-07-13 1979-02-01 Sandoz Ag SUBUNIT VACCINE
JPH0688911B2 (en) * 1985-06-06 1994-11-09 国立予防衛生研究所長 Influenza vaccine and method for producing the same
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (en) * 1999-08-16 2002-10-24 Tad Pharma Gmbh subunit vaccines
ES2359214T5 (en) * 2005-11-01 2014-10-08 Novartis Vaccines And Diagnostics Gmbh Viral vaccines derived from cells with reduced levels of residual cellular DNA by treatment with beta-propiolactone
SI2192917T1 (en) * 2007-08-28 2014-05-30 Baxter International Inc. Method for producing viral vaccines
EP3068791B1 (en) 2013-11-15 2020-07-29 Novartis AG Removal of residual cell culture impurities

Also Published As

Publication number Publication date
FR2257305B1 (en) 1982-03-19
ZA75259B (en) 1976-08-25
AU500250B2 (en) 1979-05-17
IE40794L (en) 1975-07-14
JPS50100224A (en) 1975-08-08
NO143128B (en) 1980-09-15
NL166622C (en) 1981-09-15
NL166622B (en) 1981-04-15
DK1475A (en) 1975-09-01
FI750014A (en) 1975-07-15
IE40794B1 (en) 1979-08-15
SU616997A3 (en) 1978-07-25
SE427238B (en) 1983-03-21
NO750031L (en) 1975-08-11
JPS58407B2 (en) 1983-01-06
ATA21475A (en) 1978-01-15
HU173920B (en) 1979-09-28
DE2500785A1 (en) 1975-07-31
DE2500785B2 (en) 1980-01-03
SE7500130L (en) 1975-07-15
ES433759A1 (en) 1977-02-16
BE824372A (en) 1975-07-14
AU7730575A (en) 1976-07-15
YU5875A (en) 1984-04-30
DK140003C (en) 1979-10-29
PH14458A (en) 1981-07-29
DE2500785C3 (en) 1980-09-11
FR2257305A1 (en) 1975-08-08
IL46426A0 (en) 1975-04-25
FI54053B (en) 1978-06-30
GB1498261A (en) 1978-01-18
JPS56127319A (en) 1981-10-06
HK56380A (en) 1980-10-16
DK140003B (en) 1979-06-05
CH589453A5 (en) 1977-07-15
CA1049406A (en) 1979-02-27
MY8100204A (en) 1981-12-31
NO143128C (en) 1980-12-29
IL46426A (en) 1978-01-31
FI54053C (en) 1978-10-10
JPS6035326B2 (en) 1985-08-14
CS191254B2 (en) 1979-06-29
NL7500301A (en) 1975-07-16
YU41289B (en) 1987-02-28
PL93689B1 (en) 1977-06-30
AT345449B (en) 1978-09-11

Similar Documents

Publication Publication Date Title
DK140003C (en)
AU495898B2 (en)
AU7463174A (en)
BG21555A1 (en)
BG22583A1 (en)
BG19893A1 (en)
BG20191A1 (en)
BG19770A1 (en)
BG20667A1 (en)
BG20747A2 (en)
BG20853A1 (en)
BG19650A1 (en)
AU480264A (en)
BG21445A1 (en)
CH581543A5 (en)
BG21452A1 (en)
CH1703874A4 (en)
BG21635A1 (en)
BG21675A1 (en)
BG22207A1 (en)
AU480209A (en)
BG22484A1 (en)
BG19882A1 (en)
BG23208A3 (en)
BG25978A3 (en)